Try
NEKTAR THERAPEUTICS
NKTRUnited States
48 filed reports · 499 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
48 reports · Dec 2014 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 35 | 4,283 | Mar 2015 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 5,195 | Dec 2014 to Dec 2025 |
| Current · 8-KSEC EDGAR | 1 | 2 | Mar 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 14, 2026 | 265 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 163 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 13, 2026 | 642 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 7, 2025 | 206 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 132 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 9, 2025 | 128 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 8, 2025 | 2 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 14, 2025 | 439 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 8, 2024 | 144 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 9, 2024 | 118 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 10, 2024 | 120 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 5, 2024 | 540 | Open |
Financial data
499 concepts · 9,480 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial484 concepts · 9,188 facts · Dec 2012 to Jun 2026
- Net income loss68 · Dec 2012 to Jun 2026
- Operating income loss68 · Dec 2012 to Jun 2026
- Research and development expense68 · Dec 2012 to Jun 2026
- Revenue68 · Dec 2012 to Jun 2026
- Cash and cash equivalents at carrying value66 · Dec 2012 to Jun 2026
- Allocated share based compensation expense64 · Dec 2012 to Jun 2026
- Comprehensive income net of tax64 · Dec 2012 to Jun 2026
- Costs and expenses64 · Dec 2012 to Jun 2026
- Depreciation and amortization64 · Dec 2012 to Jun 2026
- General and administrative expense (US GAAP)64 · Dec 2012 to Jun 2026
- Income tax expense benefit64 · Dec 2012 to Jun 2026
- Increase decrease in accounts payable64 · Dec 2012 to Jun 2026
- Increase decrease in other operating assets64 · Dec 2012 to Jun 2026
- Non-cash interest expense on liability related to sale of future royalties64 · Dec 2012 to Jun 2026
- Non-cash royalty revenue related to sale of future royalties64 · Dec 2012 to Jun 2026
- Nonoperating income expense64 · Dec 2012 to Jun 2026
- Other nonoperating income expense64 · Dec 2012 to Jun 2026
- Payments to acquire property plant and equipment64 · Dec 2012 to Jun 2026
- Proceeds from issuance of shares under incentive and share based compensation plans64 · Dec 2012 to Jun 2026
- Proceeds from maturities prepayments and calls of available for sale securities64 · Dec 2012 to Jun 2026
- Stockholders equity (US GAAP)63 · Dec 2012 to Jun 2026
- Increase decrease in accounts receivable62 · Dec 2012 to Dec 2025
- Increase decrease in inventories62 · Dec 2012 to Dec 2025
- Accounts payable current61 · Dec 2013 to Jun 2026
Product2 concepts · 175 facts · Dec 2016 to Jun 2026
- Revenue171 · Dec 2016 to Jun 2026
- Cost of goods and services sold (US GAAP)4 · Jun 2017 to Sep 2018
Segment7 concepts · 65 facts · Dec 2023 to Jun 2026
- Allocated share based compensation expense13 · Dec 2023 to Jun 2026
- Depreciation and amortization13 · Dec 2023 to Jun 2026
- Other Segment13 · Dec 2023 to Jun 2026
- Segment reporting other item amount13 · Dec 2023 to Jun 2026
- Impairment of long lived assets held for use9 · Dec 2023 to Dec 2025
- Gain loss on sale of property plant equipment2 · Dec 2023 to Dec 2024
- Goodwill impairment loss2 · Dec 2023 to Dec 2024
Geography3 concepts · 42 facts · Dec 2013 to Dec 2021
- Property, Plant & Equipment, Net21 · Dec 2013 to Dec 2021
- Effective income tax rate continuing operations15 · Jun 2015 to Sep 2019
- Revenue6 · Dec 2013 to Dec 2015
KPI3 concepts · 10 facts · Mar 2025 to Mar 2026
- Clinical Trial Participants5 · Mar 2025 to Dec 2025
- Treatment-Emergent Adverse Event Rate3 · Mar 2026
- EASI-100 Response Rate2 · Mar 2026
Segments
282 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service6 members · 175 facts
- Product50 · Dec 2016 to Dec 2025
- Non Cash Royalty Revenue Related To Sale Of Future Royalties47 · Dec 2016 to Jun 2026
- License Collaboration And Other Revenue45 · Dec 2016 to Dec 2025
- Royalty25 · Dec 2016 to Dec 2022
- Cash And Non Cash Royalties5 · Dec 2019 to Dec 2023
- Non Cash Royalties3 · Dec 2023 to Dec 2025
Statement business segments1 member · 65 facts
- All Other Segments65 · Dec 2023 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis7 members · 36 facts
- Us9 · Dec 2013 to Dec 2021
- IN9 · Jun 2015 to Mar 2018
- In8 · Dec 2013 to Dec 2021
- Europe3 · Dec 2013 to Dec 2015
- Germany and netherlands3 · Dec 2014 to Dec 2016
- US3 · Dec 2013 to Dec 2015
- Other countries1 · Dec 2016
Statement geographicalsrt:StatementGeographicalAxis1 member · 6 facts
- IN6 · Jun 2017 to Sep 2019
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.